Søren Kragh Moestrup
Founder at DeLiver Pharma ApS
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Niels Jonas Heilskov Graversen | M | - |
Affinicon ApS
 Affinicon ApS Pharmaceuticals: MajorHealth Technology Affinicon ApS operates as a biotechnology company. It develops combinatory drugs for treatment of diseases such as inflammation, infections, and certain forms of cancer. The firm exploits a novel platform technology for targeted delivery of known drugs to macrophages. The company was founded by Niels Jonas Heilskov Graversen on July 4, 2013 and is headquartered in Aarhus, Denmark.
DeLiver Pharma ApS
 DeLiver Pharma ApS Pharmaceuticals: MajorHealth Technology DeLiver Pharma ApS manufactures pharmaceutical products. The firm carries on business with medical development and any related business. The company was founded on March 9, 2018 and is headquartered in Odense, Denmark. | 11 years |
| Holger Jon Møller | M | - |
Affinicon ApS
Affinicon ApS Pharmaceuticals: MajorHealth Technology Affinicon ApS operates as a biotechnology company. It develops combinatory drugs for treatment of diseases such as inflammation, infections, and certain forms of cancer. The firm exploits a novel platform technology for targeted delivery of known drugs to macrophages. The company was founded by Niels Jonas Heilskov Graversen on July 4, 2013 and is headquartered in Aarhus, Denmark.
DeLiver Pharma ApS
DeLiver Pharma ApS Pharmaceuticals: MajorHealth Technology DeLiver Pharma ApS manufactures pharmaceutical products. The firm carries on business with medical development and any related business. The company was founded on March 9, 2018 and is headquartered in Odense, Denmark. | 8 years |
| Jens Kristian Damsgaard | M | - |
DeLiver Pharma ApS
DeLiver Pharma ApS Pharmaceuticals: MajorHealth Technology DeLiver Pharma ApS manufactures pharmaceutical products. The firm carries on business with medical development and any related business. The company was founded on March 9, 2018 and is headquartered in Odense, Denmark. | - |
| Søren Møller | M | 56 |
Affinicon ApS
Affinicon ApS Pharmaceuticals: MajorHealth Technology Affinicon ApS operates as a biotechnology company. It develops combinatory drugs for treatment of diseases such as inflammation, infections, and certain forms of cancer. The firm exploits a novel platform technology for targeted delivery of known drugs to macrophages. The company was founded by Niels Jonas Heilskov Graversen on July 4, 2013 and is headquartered in Aarhus, Denmark. | 8 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jason Evans | M | - |
University of Oxford
| 9 years |
| Rupert Charles de Borchgrave d'Altena | M | - |
University of Oxford
| 7 years |
| Mark Carney | M | 59 |
University of Oxford
| 3 years |
| Doron Junger | M | - |
University of Oxford
| 6 years |
| Taksz Ildiko | M | 55 |
University of Oxford
| 5 years |
| Girindre Beeharry | M | - |
University of Oxford
| 2 years |
| Truman Packard | M | - |
University of Oxford
| 7 years |
| Michael Ning | M | - |
University of Oxford
| 3 years |
| Atiff Gilli | M | 49 |
University of Oxford
| 2 years |
| Shao Ming Tong | F | 48 |
University of Oxford
| 3 years |
| Maxine Williams | F | 53 |
University of Oxford
| 3 years |
| Bruce Niven | M | - |
University of Oxford
| 4 years |
| Turi Munthe | M | 48 |
University of Oxford
| 4 years |
| Nathalie Tocci | M | 47 |
University of Oxford
| 4 years |
| Richard Wray | M | - |
University of Oxford
| 3 years |
| Paul Woodman | M | - |
University of Oxford
| 4 years |
| Ian Alistair Jensen-Humphreys | M | - |
University of Oxford
| 4 years |
| Javier Santiso Guimaras | M | 55 |
University of Oxford
| 3 years |
| Rachel Clare Empey | F | 48 |
University of Oxford
| 3 years |
| Jim Maun | M | - |
University of Oxford
| 3 years |
| Siddhartha Sandilya | M | - |
University of Oxford
| 3 years |
| Lucy Heintz | F | 52 |
University of Oxford
| 3 years |
| Rajesh Swaminathan | M | - |
University of Oxford
| 2 years |
| Peter A. Chew | M | - |
University of Oxford
| 1 years |
| Paul Gannon | M | 50 |
University of Oxford
| 3 years |
| Dacia Toll | F | - |
University of Oxford
| 2 years |
| Daniel Wilson Dodd | M | - |
University of Oxford
| 3 years |
| Martin Le Huray | M | - |
University of Oxford
| 1 years |
| Philip Krinks | M | - |
University of Oxford
| 4 years |
| Tracy Bownes | M | - |
University of Oxford
| 4 years |
| Zain Azmir Zain Azahari | M | - |
University of Oxford
| 3 years |
| Nailesh Rambhai | M | - |
University of Oxford
| 3 years |
| Alex Murray | M | - |
University of Oxford
| 4 years |
| MICHAEL DAL BELLO | M | - |
University of Oxford
| 2 years |
| Nimit Shah | M | - |
University of Oxford
| 3 years |
| Alistair Maclay | M | - |
University of Oxford
| 3 years |
| Theo Gott | M | - |
University of Oxford
| 4 years |
| Nanna Liebach Lüneborg | M | 49 |
Affinicon ApS
Affinicon ApS Pharmaceuticals: MajorHealth Technology Affinicon ApS operates as a biotechnology company. It develops combinatory drugs for treatment of diseases such as inflammation, infections, and certain forms of cancer. The firm exploits a novel platform technology for targeted delivery of known drugs to macrophages. The company was founded by Niels Jonas Heilskov Graversen on July 4, 2013 and is headquartered in Aarhus, Denmark. | - |
| Robin Bell Jones | M | - |
University of Oxford
| 5 years |
| Frank Lampen | M | - |
University of Oxford
| 3 years |
| Adrian Woolfson | M | 60 |
University of Oxford
| 3 years |
| Gavin Screaton | M | - |
University of Oxford
| 3 years |
| Johnny Carew Pole | M | - |
University of Oxford
| 3 years |
| Kar Lun Fung | M | 47 |
University of Oxford
| 4 years |
| Chris Watt | M | - |
University of Oxford
| 4 years |
| Will Pearson | M | - |
University of Oxford
| 4 years |
| Julia Black | F | - |
University of Oxford
| 4 years |
| Yong Ping Liu | M | 69 |
University of Oxford
| 3 years |
| Zoe King | F | - |
University of Oxford
| 4 years |
| Richard Sanders | M | 48 |
University of Oxford
| 3 years |
| Carolyn Campbell | M | - |
University of Oxford
| 5 years |
| Todd Martin Millay | M | - |
University of Oxford
| 1 years |
| Zeina Bain | F | 46 |
University of Oxford
| 3 years |
| Thomas Casdagli | M | 47 |
University of Oxford
| 4 years |
| James Mitchell | M | 51 |
University of Oxford
| 4 years |
| John de Mello | M | - |
University of Oxford
| 4 years |
| Azeem Azhar | M | - |
University of Oxford
| 4 years |
| Chris Gradel | M | 51 |
University of Oxford
| 1 years |
| Maxim Shashenkov | M | - |
University of Oxford
| 4 years |
| Andrew McMullan | M | - |
University of Oxford
| 4 years |
| Jonah Martin Edelman | M | - |
University of Oxford
| 3 years |
| Carolyn Anne Prowse | F | 52 |
University of Oxford
| 4 years |
| Nathan Zibilich | M | - |
University of Oxford
| 2 years |
| Emma Griffin | F | 52 |
University of Oxford
| 4 years |
| John Ferris Watkins | M | 72 |
University of Oxford
| 1 years |
| Christopher Edwards | M | 51 |
University of Oxford
| 1 years |
| Katrin Burt | F | 48 |
University of Oxford
| 3 years |
| David Kneale | M | - |
University of Oxford
| 4 years |
| Jeremy Charles Green | M | 49 |
University of Oxford
| 3 years |
| Xavier Woodward | M | - |
University of Oxford
| 4 years |
| Josephine Shea | F | - |
University of Oxford
| 2 years |
| Michelle Riley | F | - |
University of Oxford
| 2 years |
| Clare Hawkins | F | - |
University of Oxford
| 4 years |
| Henrik Kraft | M | 50 |
University of Oxford
| 1 years |
| Jamie Metzl | M | - |
University of Oxford
| 4 years |
| Hugh F. Durrant-Whyte | M | - |
University of Oxford
| 8 years |
| Camilla Palladino | F | - |
University of Oxford
| 4 years |
| Robert Harrington | M | - |
University of Oxford
| 4 years |
| Lisette Nieves | M | - |
University of Oxford
| 2 years |
| Tom Salmon | M | - |
University of Oxford
| 3 years |
| Siddharth T. Patel | M | 47 |
University of Oxford
| 4 years |
| Samuel Nickless | M | - |
University of Oxford
| 3 years |
| Helen Cullyer | M | - |
University of Oxford
| 1 years |
| Deepak Ramachandran | M | - |
University of Oxford
| 4 years |
| Scott Weiner | M | - |
University of Oxford
| 6 years |
| Frank Campbell | M | - |
University of Oxford
| 4 years |
| Christopher D. Anderson | M | - |
University of Oxford
| 4 years |
| Wing Ting Fu Kwong | F | 55 |
University of Oxford
| 1 years |
| Carlos Elizondo Mayer-Serra | M | 62 |
University of Oxford
| 3 years |
| Rebecca Gibson | F | - |
University of Oxford
| 3 years |
| Benjamin Holmes | M | 50 |
University of Oxford
| 3 years |
| Roy Bahat | M | - |
University of Oxford
| 4 years |
| John F. Hillen | M | 58 |
University of Oxford
| 3 years |
| Jonathan Montagu | M | - |
University of Oxford
| 5 years |
| Matteo Stefanel | M | 49 |
University of Oxford
| 3 years |
| Georgina Wells | F | - |
University of Oxford
| 3 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United Kingdom | 95 | 95.00% |
| Denmark | 5 | 5.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Søren Kragh Moestrup
- Personal Network
